December 31, 2015: Researchers First Used CRISPR to Treat a Genetic Disease in Mice
Researchers at the Duke University used CRISPR technology to treat Duchenne Muscular Dystrophy (DMD), and published the report on December 31, 2015 on Science journal. DMD is a genetic disease that can also occur in humans. This was the first case in which CRISPR technology is used to treat inherited diseases in adult mammals and was of great importance to the development of human gene therapy.
Reference
http://www.sciencemag.org/news/2015/12/crispr-helps-heal-mice-muscular-dystrophy
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02